Background Wearable sensor technologies have the potential to improve monitoring in
people with multiple sclerosis (MS) and inform timely disease management decisions …

Background: Reduced mobility is a central feature of COPD. Assessment of mobility
outcomes that can be measured digitally (digital mobility outcomes (DMOs)) in daily life such …

Background Although digital mobility outcomes (DMOs) can be readily calculated from real-
world data collected with wearable devices and ad-hoc algorithms, technical validation is …

Introduction: Accurately assessing people's gait, especially in real-world conditions and in
case of impaired mobility, is still a challenge due to intrinsic and extrinsic factors resulting in …

Background The development of optimal strategies to treat impaired mobility related to
ageing and chronic disease requires better ways to detect and measure it. Digital health …

Objectives To evaluate trends in the prevalence of physical activity (PA) from 2014 to 2020;
to identify sex differences and sociodemographic and health-related factors associated with …

This study aimed to validate a wearable device's walking speed estimation pipeline,
considering complexity, speed, and walking bout duration. The goal was to provide …

Background Gait characteristics are important risk factors for falls, hospitalisations and
mortality in older adults, but the impact of COPD on gait performance remains unclear. We …

The loss of mobility is a common trait in multiple health conditions (eg, Parkinson's disease)
and is associated with reduced quality of life. In this context, being able to monitor mobility in …

Rationale The effect of pharmacological and non-pharmacological interventions on physical
activity (PA) outcomes is not fully elucidated in patients with COPD. The objectives of the …